CINCINNATI, Apr. 24 (Korea Bizwire) — As the global community gathers for World Malaria Day to celebrate successes and plot strategy to eliminate the disease from the face of the earth, a new ray of hope is emerging from a surprising place: the testing side of the equation. Meridian Bioscience, Inc. of Cincinnati, Ohio (NASDAQ:VIVO) [...]
CINCINNATI, Aug. 30 (Korea Bizwire) — Meridian Bioscience, Inc. (NASDAQ:VIVO) was awarded 1st place for innovation in emergency treatment and point-of-care testing for its illumigene® Malaria test at the 2016 JIB/ACNBH Conference this summer. Innovations from worldwide companies contributing to the development of the Medical Biology industry were put under the spotlight at this year’s [...]
CINCINNATI, Jan. 26 (Korea Bizwire) — Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that it has received the CE Mark for illumigene® Malaria, a novel, highly accurate test developed by Meridian with the technical assistance of the Centers for Disease Control and Prevention (CDC) and Cheikh Anta Diop University of Dakar, Senegal. The test is up to 80,000 [...]